Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2625 of 3546 entries
View as:

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01436110 Org: User:
Start: 09/30/11 End: 09/30/12 Due: 09/30/13

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT00225862 Org: User:
Start: 01/31/05 End: 12/31/05 Due: 12/31/06

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03376932 Org: User:
Start: 01/18/19 End: 02/03/21 Due: 02/03/22

A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212

Phase: N/A Priority: Normal
NCT ID: NCT01658553 Org: User:
Start: 09/19/12 End: 04/05/14 Due: 04/05/15

A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive

Phase: N/A Priority: Normal
NCT ID: NCT06433921 Org: User:
Start: 08/14/24 End: 08/14/26 Due: 08/14/27

Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling

Phase: N/A Priority: Normal
NCT ID: NCT01868022 Org: User:
Start: 10/09/13 End: 10/24/17 Due: 10/24/18

ARIXTRA® Adherence in SVT Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01691495 Org: User:
Start: 10/31/12 End: 08/31/14 Due: 08/31/15

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416

Phase: N/A Priority: Normal
NCT ID: NCT00680485 Org: User:
Start: 06/30/07 End: 10/31/07 Due: 10/31/08

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00392743 Org: User:
Start: 12/31/06 End: 05/31/07 Due: 05/31/08

Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair

Phase: N/A Priority: Normal
NCT ID: NCT01920594 Org: User:
Start: 10/31/13 End: 10/08/14 Due: 10/08/15

A First Time In Human Study To Assess The Compound GSK615915

Phase: N/A Priority: Normal
NCT ID: NCT00400660 Org: User:
Start: 11/23/05 End: 07/03/06 Due: 07/03/07

Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00347139 Org: User:
Start: 05/23/06 End: 01/10/07 Due: 01/10/08

Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™

Phase: N/A Priority: Normal
NCT ID: NCT00680914 Org: User:
Start: 06/10/08 End: 05/08/09 Due: 05/08/10

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00104403 Org: User:
Start: 12/31/04 End: 01/31/06 Due: 01/31/07

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT02184572 Org: User:
Start: 08/25/14 End: 12/22/15 Due: 12/22/16

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02586506 Org: User:
Start: 10/01/15 End: 02/04/16 Due: 02/04/17

Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster

Phase: N/A Priority: Normal
NCT ID: NCT04091451 Org: User:
Start: 09/17/19 End: 02/15/24 Due: 02/15/25

A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.

Phase: N/A Priority: Normal
NCT ID: NCT00379990 Org: User:
Start: 01/31/06 End: 12/31/07 Due: 12/31/08

Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01207999 Org: User:
Start: 10/31/07 End: 03/31/10 Due: 03/31/11

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00920088 Org: User:
Start: 06/30/09 End: 11/30/09 Due: 11/30/10

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes

Phase: N/A Priority: Normal
NCT ID: NCT00992511 Org: User:
Start: 10/14/09 End: 11/09/10 Due: 11/09/11

A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01372410 Org: User:
Start: 07/01/11 End: 10/27/11 Due: 10/27/12

Bioequivalence Study of Montelukast 5 mg Chewable

Phase: N/A Priority: Normal
NCT ID: NCT01863654 Org: User:
Start: 05/16/10 End: 05/26/10 Due: 05/26/11

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B

Phase: N/A Priority: Normal
NCT ID: NCT00697840 Org: User:
Start: 06/30/95 End: 01/31/96 Due: 01/31/97

Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01299558 Org: User:
Start: 05/17/10 End: 07/15/10 Due: 07/15/11